Sign up to save your podcasts
Or
Share E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo. I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum!
View all episodes
By Michael Putman
4.9
113113 ratings
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo. I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum!
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
323 Listeners
JAMA Clinical Reviews
499 Listeners
This Week in Cardiology
876 Listeners
Rheumnow Podcast
131 Listeners
Core IM | Internal Medicine Podcast
1,146 Listeners
Healio Rheuminations
121 Listeners
Annals On Call Podcast
192 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
ACR on Air
67 Listeners
Run the List
247 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
Rheumatology For The Royal College
183 Listeners
RheumMadness Rheumatology Podcast
11 Listeners
ACR Journals On Air
18 Listeners
Talking Rheumatology Spotlight
6 Listeners